NCT03748108View on ClinicalTrials.gov

Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

March 30, 2020

Study Completion Date

August 1, 2020

Conditions
Abdominal Hysterectomy
Interventions
DRUG

lidocaine

a bolus intravenous dose of 1.5 mg/kg lidocaine 2% over 15 s just before the induction of general anesthesia.

DRUG

Placebo

a bolus intravenous dose of 1.5 mg/ kg a saline placebo over 15 s just before the induction of general anesthesia.

Trial Locations (1)

81528

Aswan University, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03748108 - Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy | Biotech Hunter | Biotech Hunter